A carregar...
Combining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapy
PURPOSE OF REVIEW: The autologous antigen-presenting cell immunotherapy, sipuleucel-T, was the first and remains the only US Food and Drug Administration-approved immunotherapy for prostate cancer. In this article, we will summarize recent clinical data on several additional immune-directed strategi...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3444804/ https://ncbi.nlm.nih.gov/pubmed/22410456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e32835205a0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|